NewsBenzingaThe FDA Clears United Therapeutics' Investigational New Drug Application To Proceed With SUMMIT Trial Of Treprostinil Soft Mist Inhaler In Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease The FDA Clears United Therapeutics' Investigational New Drug Application To Proceed With SUMMIT Trial Of Treprostinil Soft Mist Inhaler In Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease Benzinga 2026.10.19 11:09 (GMT+0) Open on Benzinga Other news Brandywine Realty Tr Q3 FFO $0.14, Inline, Sales $125.638M Beat $121.617M Estimate FS Bancorp Q3 EPS $0.63 Misses $0.98 Estimate, Sales $40.193M Beat $35.128M Estimate Oak Valley Q3 EPS $0.77 Down From $0.81 YoY, Sales $21.653M Up From $21.170M YoY Meta Platforms Says Co. Entered Into A Founder Alignment Agreement With Mark Zuckerberg First BanCorp. Announces $350M Buyback Plan Wyndham Hotels & Resorts Raises FY2026 Adj EPS Guidance from $4.71-$4.83 to $4.84-$4.92 vs $4.80 Est; Affirms FY2026 Sales Guidance of $1.480B-$1.500B vs $1.481B Est
Wyndham Hotels & Resorts Raises FY2026 Adj EPS Guidance from $4.71-$4.83 to $4.84-$4.92 vs $4.80 Est; Affirms FY2026 Sales Guidance of $1.480B-$1.500B vs $1.481B Est
